Literature DB >> 9464032

Clinical implications of ketorolac for postoperative analgesia.

M A Fiedler1.   

Abstract

Ketorolac is the only nonsteroidal anti-inflammatory drug (NSAID) in widespread clinical use that is available in an injectable form. Though similar to aspirin and ibuprofen, it is much more potent. In fact, it is potent enough to be useful for postsurgical pain either alone or in combination with other pain relief strategies. For many types of pain, ketorolac is comparable in potency with opioids though the mechanism by which it relieves pain is significantly different. Ketorolac has a much longer duration than morphine or meperidine but has a slower onset. Though we sometimes perceive NSAIDs as almost harmless, ketorolac is a potent drug and, like other potent drugs, has the potential to produce potent adverse effects including organ disfunction and allergic reaction. Risk factors for these adverse effects are well understood, allowing the clinician to plan the ketorolac use safely. Well planned patient selection and ketorolac administration can improve patient care by reducing opioid side effects and improving analgesia while speeding patient recovery and PACU discharge times.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9464032     DOI: 10.1016/s1089-9472(97)90006-x

Source DB:  PubMed          Journal:  J Perianesth Nurs        ISSN: 1089-9472            Impact factor:   1.084


  2 in total

1.  Gastrointestinal-resident, shape-changing microdevices extend drug release in vivo.

Authors:  Arijit Ghosh; Ling Li; Liyi Xu; Ranjeet P Dash; Neha Gupta; Jenny Lam; Qianru Jin; Venkata Akshintala; Gayatri Pahapale; Wangqu Liu; Anjishnu Sarkar; Rana Rais; David H Gracias; Florin M Selaru
Journal:  Sci Adv       Date:  2020-10-28       Impact factor: 14.136

2.  Ketorolac for Pain Control With Intrauterine Device Placement: A Randomized Controlled Trial.

Authors:  Lynn L Ngo; Kristy K Ward; Sheila K Mody
Journal:  Obstet Gynecol       Date:  2015-07       Impact factor: 7.661

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.